• BIO-key International’s Nasdaq trading will resume on Wednesday, July 8, 2026, following a prior trading halt.
• Nasdaq determined the company has regained compliance with continued listing standards, including minimum bid price and periodic reporting.
• The stock will remain under exchange monitoring for one year, through July 6, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief on July 07, 2026, and is solely responsible for the information contained therein.